Improvement of stem cell-derived exosome release efficiency by surface-modified nanoparticles

Area of Science:

• Biotechnology
• Cell Biology
• Nanomedicine

Background:

• Mesenchymal stem cells (MSCs) produce extracellular vesicles (EVs), including exosomes, with therapeutic potential.
• Current limitations in exosome production yield and quantification hinder their clinical application.
• Nanoscale MSC-derived exosomes are explored as bio-stable nanomaterials.

Purpose of the Study:

• To investigate the molecular mechanisms underlying exosome generation stimulated by nanoparticles.
• To compare the internalization of surface-modified nanoparticles and their effect on exosome release from MSCs.

Main Methods:

• Utilized surface-modified, positively charged nanoparticles for MSC treatment.
• Analyzed exosome generation and related molecular markers, including Rab7.
• Investigated nanoparticle internalization pathways, such as clathrin-mediated endocytosis.

Main Results:

• Increased expression of Rab7, a marker for late endosomes and autophagosomes, was observed during enhanced exosome production.
• Rab7 expression correlated with autophagosome formation, indicating a role in exosome biogenesis.
• Nanoparticles were found to be transported to lysosomes via clathrin-mediated endocytosis.

Conclusions:

• Developed nanoparticles are internalized by MSCs through clathrin-mediated endocytosis.
• Internalized nanoparticles stimulate autophagy-related factors, promoting exosome release.
• Nanoparticle-mediated enhancement of MSC exosome production offers potential for increased yield and discovery of novel genetic factors.